NCT05125094View on ClinicalTrials.gov

Prognostic Performance of Preoperative and Follow by Gadoxetic Enhanced MRI in HCC Patients After TACE

Not yet recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

July 31, 2024

Study Completion Date

December 30, 2025

Conditions

Hepatocellular Carcinoma Stage III

Interventions

DEVICE

TACE,Ablation

Transcatheter arterial chemoembolization

All Listed Sponsors

lead

Shanghai Zhongshan Hospital

OTHER

NCT05125094 - Prognostic Performance of Preoperative and Follow by Gadoxetic Enhanced MRI in HCC Patients After TACE | Biotech Hunter | Biotech Hunter